Chemerin: A multifaceted adipokine involved in metabolic disorders
View/ Open
Main article (3.940Mb)
Download
Publication date
2018-05-30Rights
© 2018 The authors. Published by Bioscientifica Ltd. This work is licensed under a Creative Commons Attribution 4.0 Unported License.Peer-Reviewed
YesOpen Access status
openAccessAccepted for publication
2018-05-30
Metadata
Show full item recordAbstract
Metabolic syndrome is a global public health problem and predisposes individuals to obesity, diabetes and cardiovascular disease. Although the underlying mechanisms remain to be elucidated, accumulating evidence has uncovered a critical role of adipokines. Chemerin, encoded by the gene Rarres2, is a newly discovered adipokine involved in inflammation, adipogenesis, angiogenesis and energy metabolism. In humans, local and circulating levels of chemerin are positively correlated with body mass index and obesity-related biomarkers. In this review, we discuss both peripheral and central roles of chemerin in regulating body metabolism. In general, chemerin is upregulated in obese and diabetic animals. Previous studies by gain or loss of function show an association of chemerin with adipogenesis, glucose homeostasis, food intake and body weight. In the brain, the hypothalamus integrates peripheral afferent signals including adipokines to regulate appetite and energy homeostasis. Chemerin increases food intake in seasonal animals by acting on hypothalamic stem cells, the tanycytes. In peripheral tissues, chemerin increases cell expansion, inflammation and angiogenesis in adipose tissue, collectively resulting in adiposity. While chemerin signalling enhances insulin secretion from pancreatic islets, contradictory results have been reported on how chemerin links to obesity and insulin resistance. Given the association of chemerin with obesity comorbidities in humans, advances in translational research targeting chemerin are expected to mitigate metabolic disorders. Together, the exciting findings gathered in the last decade clearly indicate a crucial multifaceted role for chemerin in the regulation of energy balance, making it a promising candidate for urgently needed pharmacological treatment strategies for obesity.Version
Published versionCitation
Helfer G and Wu Q-F (2018) Chemerin: A multifaceted adipokine involved in metabolic disorders. Journal of Endocrinology. 238(2): R79–R94Link to Version of Record
https://doi.org/10.1530/JOE-18-0174Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.1530/JOE-18-0174